MENU
+Compare
NNVC
Stock ticker: ASE
AS OF
Dec 20 closing price
Price
$1.49
Change
+$0.04 (+2.76%)
Capitalization
21.38M

NNVC NanoViricides Forecast, Technical & Fundamental Analysis

a developer of anti-viral therapeutics

Industry Biotechnology
NNVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for NNVC with price predictions
Dec 20, 2024

NNVC saw its Stochastic Oscillator peaks and leaves the overbought zone

The Stochastic Oscillator for NNVC moved out of overbought territory on December 11, 2024. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 30 similar instances where the indicator exited the overbought zone. In of the 30 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 19, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on NNVC as a result. In of 103 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NNVC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NNVC broke above its upper Bollinger Band on December 06, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where NNVC's RSI Indicator exited the oversold zone, of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NNVC just turned positive on November 25, 2024. Looking at past instances where NNVC's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

NNVC moved above its 50-day moving average on December 05, 2024 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for NNVC crossed bullishly above the 50-day moving average on December 10, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NNVC advanced for three days, in of 197 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 119 cases where NNVC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.115) is normal, around the industry mean (14.556). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). NNVC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (256.215).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NNVC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NNVC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
NNVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NNVC is expected to report earnings to fall 48.48% to -17 cents per share on August 30

NanoViricides NNVC Stock Earnings Reports
Q2'23
Est.
$-0.17
Q1'24
Missed
by $0.18
Q4'23
Missed
by $0.01
Q3'23
Est.
$-0.17
Q1'23
Est.
$-0.15
The last earnings report on May 14 showed earnings per share of -33 cents, missing the estimate of -15 cents. With 547.88K shares outstanding, the current market capitalization sits at 21.38M.
A.I. Advisor
published General Information

General Information

a developer of anti-viral therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1 Controls Drive
Phone
+1 203 937-6137
Employees
7
Web
http://www.nanoviricides.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SGRY21.221.61
+8.21%
Surgery Partners
BFLY3.090.12
+4.04%
Butterfly Network
CTXR2.600.03
+1.17%
Citius Pharmaceuticals Inc
EC7.640.02
+0.26%
Ecopetrol SA
MATW27.55-0.16
-0.58%
Matthews International Corp

NNVC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NNVC has been loosely correlated with MDGL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NNVC jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NNVC
1D Price
Change %
NNVC100%
+2.76%
MDGL - NNVC
34%
Loosely correlated
+5.12%
CYTK - NNVC
31%
Poorly correlated
+4.56%
IFRX - NNVC
30%
Poorly correlated
+5.16%
AXON - NNVC
29%
Poorly correlated
+2.60%
ORMP - NNVC
28%
Poorly correlated
-4.82%
More